Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson’s disease: results of the Italian GLORIA patient population

被引：0
作者：
Angelo Antonini
Pietro Marano
Graziano Gusmaroli
Nicola Modugno
Claudio Pacchetti
Mariachiara Sensi
Gabriella Melzi
Lars Bergmann
Maurizio Zibetti
Leonardo Lopiano
机构：
[1] University of Padua,Parkinson and Movement Disorders Unit, Department of Neuroscience
[2] Madonna del Rosario Clinic,Neurology Unit
[3] Ospedale degli Infermi,Parkinson’s Disease and Movement Disorders Unit
[4] IRCCS Neuromed,Neurology Unit
[5] IRCCS C. Mondino Foundation,Medical Department
[6] Sant’Anna University Hospital,Department of Neuroscience
[7] AbbVie s.r.l.,undefined
[8] AbbVie Inc.,undefined
[9] University of Torino,undefined
来源：
Neurological Sciences | 2020年 / 41卷
关键词：
Parkinson’s disease; Levodopa-carbidopa intestinal gel; Motor symptoms; Non-motor symptoms; Quality of life; Routine patient care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2929 / 2937
页数：8
相关论文
共 237 条
  • [1] Obeso JA(2000)Levodopa motor complications in Parkinson’s disease Trends Neurosci 23 S2-1389
  • [2] Olanow CW(2007)Levodopa induced dyskinesias Mov Disord 22 1379-908
  • [3] Nutt JG(2018)Medical and surgical management of advanced Parkinson’s disease Mov Disord 33 900-723
  • [4] Fabbrini G(2011)Parkinson’s disease: the non-motor issues Parkinsonism Relat Disord 17 717-140
  • [5] Brotchie JM(2013)Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease J Neurol Sci 332 136-2445
  • [6] Grandas F(2014)Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients J Neurol 261 2438-23
  • [7] Nomoto M(2016)Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: an open-label prospective observational study of effectiveness, tolerability and healthcare costs Parkinsonism Relat Disord 29 17-129
  • [8] Goetz CG(2010)Oral and infusion levodopa- based strategies for managing motor complications in patients with Parkinson’s disease CNS Drugs 24 119-261
  • [9] Antonini A(2010)Pharmacokinetics of levodopa J Neurol 257 253-S584
  • [10] Moro E(2008)Pharmacokinetics and pharmacodynamics of levodopa Mov Disord 23 S580-230
12345678910